{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:42:51Z","timestamp":1793148171463,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012544","name":"China Medical University, Taiwan","doi-asserted-by":"publisher","award":["CMU113-S-25"],"award-info":[{"award-number":["CMU113-S-25"]}],"id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012544","name":"China Medical University, Taiwan","doi-asserted-by":"publisher","award":["CMU113-S-52"],"award-info":[{"award-number":["CMU113-S-52"]}],"id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC 112-2320-B-039-040-MY2"],"award-info":[{"award-number":["NSTC 112-2320-B-039-040-MY2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-026-05302-9","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:45:41Z","timestamp":1771919141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuroprotective effects of icariin in animal models of depression and anxiety: a systematic review of preclinical studies"],"prefix":"10.1186","volume":"26","author":[{"given":"Jin-Xuan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-An","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Lin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Shiou","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"6","key":"5302_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/da.22230","volume":"31","author":"AJ Baxter","year":"2014","unstructured":"Baxter AJ, et al. Challenging the myth of an epidemic of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010. Depress Anxiety. 2014;31(6):506\u201316.","journal-title":"Depress Anxiety"},{"issue":"Suppl 1","key":"5302_CR2","first-page":"3","volume":"7","author":"JP L\u00e9pine","year":"2011","unstructured":"L\u00e9pine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3\u20137.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"5302_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2165\/00002018-199818010-00005","volume":"18","author":"P Mourilhe","year":"1998","unstructured":"Mourilhe P, Stokes PE. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression. Drug Saf. 1998;18(1):57\u201382.","journal-title":"Drug Saf"},{"issue":"22","key":"5302_CR4","doi-asserted-by":"publisher","first-page":"12022","DOI":"10.3390\/ijerph182212022","volume":"18","author":"JK Hohls","year":"2021","unstructured":"Hohls JK, et al. Anxiety, depression and quality of life \u2013 a systematic review of evidence from longitudinal observational studies. Int J Environ Res Public Health. 2021;18(22):12022.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"5302_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.37349\/en.2024.00050","volume":"3","author":"C Vollbracht","year":"2024","unstructured":"Vollbracht C, Werner M. The role of inflammation and oxidative stress in the pathophysiology of depressions: time to consider vitamin C deficiency. Explor Neurosci. 2024;3(4):287\u201394.","journal-title":"Explor Neurosci"},{"key":"5302_CR6","doi-asserted-by":"publisher","first-page":"1046599","DOI":"10.3389\/fphar.2022.1046599","volume":"13","author":"A Kabra","year":"2022","unstructured":"Kabra A, et al. Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression. Front Pharmacol. 2022;13:1046599.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5302_CR7","first-page":"22","volume":"3","author":"JM Ferguson","year":"2001","unstructured":"Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry. 2001;3(1):22\u20137.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"5302_CR8","unstructured":"Santaguida PL, et al. Treatment for depression after unsatisfactory response to SSRIs. Agency for Healthcare Research and Quality; 2012."},{"issue":"10","key":"5302_CR9","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.3390\/biomedicines10102597","volume":"10","author":"H Hussain","year":"2022","unstructured":"Hussain H, et al. Investigation of antistress and antidepressant activities of synthetic Curcumin analogues: behavioral and biomarker approach. Biomedicines. 2022;10(10):2597.","journal-title":"Biomedicines"},{"key":"5302_CR10","doi-asserted-by":"publisher","first-page":"1411168","DOI":"10.3389\/fphar.2024.1411168","volume":"15","author":"A Alizadeh","year":"2024","unstructured":"Alizadeh A, et al. Flavonoids against depression: a comprehensive review of literature. Front Pharmacol. 2024;15:1411168.","journal-title":"Front Pharmacol"},{"issue":"12","key":"5302_CR11","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1248\/bpb.29.2399","volume":"29","author":"Y Pan","year":"2006","unstructured":"Pan Y, et al. Effects of Icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats. Biol Pharm Bull. 2006;29(12):2399\u2013403.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"5302_CR12","first-page":"12","volume":"8","author":"J Jiang","year":"2016","unstructured":"Jiang J, et al. Pharmacology and clinical application of plants in Epimedium L. Chin Herb Med. 2016;8(1):12\u201323.","journal-title":"Chin Herb Med"},{"issue":"11","key":"5302_CR13","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3736\/jcim20111104","volume":"9","author":"Y Chen","year":"2011","unstructured":"Chen Y, et al. Icariin and its pharmaceutical efficacy: research progress of molecular mechanism]. Zhong Xi Yi Jie He Xue Bao. 2011;9(11):1179\u201384.","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"5302_CR14","doi-asserted-by":"publisher","first-page":"113180","DOI":"10.1016\/j.biopha.2022.113180","volume":"151","author":"Z Bi","year":"2022","unstructured":"Bi Z, Zhang W, Yan X. Anti-inflammatory and immunoregulatory effects of Icariin and Icaritin. Biomed Pharmacother. 2022;151:113180.","journal-title":"Biomed Pharmacother"},{"key":"5302_CR15","doi-asserted-by":"publisher","first-page":"115303","DOI":"10.1016\/j.expneurol.2025.115303","volume":"390","author":"X Lei","year":"2025","unstructured":"Lei X, et al. Icariin attenuates oxidative stress via SIRT1\/PGC-1\u03b1 pathway in SAH mice. Exp Neurol. 2025;390:115303.","journal-title":"Exp Neurol"},{"key":"5302_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3389\/fphar.2018.00474","volume":"9","author":"MX Ho","year":"2018","unstructured":"Ho MX, et al. Icariin, but not genistein, exerts osteogenic and anti-apoptotic effects in osteoblastic cells by selective activation of non-genomic ER\u03b1 signaling. Front Pharmacol. 2018;9:474.","journal-title":"Front Pharmacol"},{"key":"5302_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuroscience.2015.02.053","volume":"294","author":"B Liu","year":"2015","unstructured":"Liu B, et al. Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation. Neuroscience. 2015;294:193\u2013205.","journal-title":"Neuroscience"},{"key":"5302_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpba.2016.02.001","volume":"123","author":"MJ Gong","year":"2016","unstructured":"Gong MJ, et al. Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network disturbances revealed by NMR-based metabonomics in rats. J Pharm Biomed Anal. 2016;123:63\u201373.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"5302_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/pharmaceutics11020051","volume":"11","author":"LY Han","year":"2019","unstructured":"Han LY, et al. Improved pharmacokinetics of Icariin (ICA) within formulation of PEG-PLLA\/PDLA-PNIPAM polymeric micelles. Pharmaceutics. 2019;11(2):51.","journal-title":"Pharmaceutics"},{"key":"5302_CR20","doi-asserted-by":"crossref","unstructured":"Tan HL et al. Anti-cancer properties of the naturally occurring aphrodisiacs: Icariin and its derivatives. Front Pharmacol. 2016;7:191.","DOI":"10.3389\/fphar.2016.00191"},{"issue":"7","key":"5302_CR21","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","volume":"13","author":"MY Liu","year":"2018","unstructured":"Liu MY, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 2018;13(7):1686\u201398.","journal-title":"Nat Protoc"},{"issue":"6","key":"5302_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nprot.2012.044","volume":"7","author":"DA Slattery","year":"2012","unstructured":"Slattery DA, Cryan JF. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc. 2012;7(6):1009\u201314.","journal-title":"Nat Protoc"},{"issue":"4","key":"5302_CR23","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.pbb.2005.11.010","volume":"82","author":"Y Pan","year":"2005","unstructured":"Pan Y, et al. Antidepressant-like effect of Icariin and its possible mechanism in mice. Pharmacol Biochem Behav. 2005;82(4):686\u201394.","journal-title":"Pharmacol Biochem Behav"},{"key":"5302_CR24","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"5302_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fphys.2019.00203","volume":"10","author":"N Mikolajewicz","year":"2019","unstructured":"Mikolajewicz N, Komarova SV. Meta-analytic methodology for basic research: a practical guide. Front Physiol. 2019;10:203.","journal-title":"Front Physiol"},{"key":"5302_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jclinepi.2023.04.017","volume":"159","author":"TF Frandsen","year":"2023","unstructured":"Frandsen TF, Eriksen MB. Supplementary strategies identified additional eligible studies in qualitative systematic reviews. J Clin Epidemiol. 2023;159:85\u201391.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"5302_CR27","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/brainsci12101287","volume":"12","author":"DD Markov","year":"2022","unstructured":"Markov DD. Sucrose preference test as a measure of anhedonic behavior in a chronic unpredictable mild stress model of depression: outstanding issues. Brain Sci. 2022;12(10):1287.","journal-title":"Brain Sci"},{"key":"5302_CR28","doi-asserted-by":"crossref","unstructured":"Qi CC, Ding YQ, Zhou JN. Biological factors influencing the mice forced swim test. J Neurol Neuromed. 2016;1(4):21\u20134","DOI":"10.29245\/2572.942X\/2016\/4.1033"},{"key":"5302_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, et al. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"5302_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/jrsm.1232","volume":"8","author":"BU Burda","year":"2017","unstructured":"Burda BU, et al. Estimating data from figures with a web-based program: considerations for a systematic review. Res Synth Methods. 2017;8(3):258\u201362.","journal-title":"Res Synth Methods"},{"key":"5302_CR31","doi-asserted-by":"publisher","first-page":"e24260","DOI":"10.7554\/eLife.24260","volume":"6","author":"PP Zwetsloot","year":"2017","unstructured":"Zwetsloot PP, et al. Standardized mean differences cause funnel plot distortion in publication bias assessments. eLife. 2017;6:e24260.","journal-title":"eLife"},{"key":"5302_CR32","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fphar.2020.00880","volume":"11","author":"X Zou","year":"2020","unstructured":"Zou X, et al. Icariin attenuates amyloid-\u03b2 (A\u03b2)-induced neuronal insulin resistance through PTEN downregulation. Front Pharmacol. 2020;11:880.","journal-title":"Front Pharmacol"},{"issue":"7","key":"5302_CR33","first-page":"987","volume":"33","author":"XX Zhang","year":"2017","unstructured":"Zhang XX, et al. Antidepressant effects of Icariin in prenatally stressed offspring. Chin Pharm Bull. 2017;33(7):987\u201391.","journal-title":"Chin Pharm Bull"},{"issue":"20","key":"5302_CR34","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.3390\/molecules24203700","volume":"24","author":"LH Cao","year":"2019","unstructured":"Cao LH, et al. PI3K-AKT signaling activation and icariin: the potential effects on the perimenopausal depression-like rat model. Molecules. 2019;24(20):3700.","journal-title":"Molecules"},{"key":"5302_CR35","doi-asserted-by":"publisher","first-page":"105799","DOI":"10.1016\/j.intimp.2019.105799","volume":"75","author":"L Liu","year":"2019","unstructured":"Liu L, et al. Icariin and Icaritin ameliorated hippocampus neuroinflammation via mediating HMGB1 expression in social defeat model in mice. Int Immunopharmacol. 2019;75:105799.","journal-title":"Int Immunopharmacol"},{"key":"5302_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.intimp.2018.12.055","volume":"68","author":"L Liu","year":"2019","unstructured":"Liu L, et al. Icariin and Icaritin ameliorated hippocampus neuroinflammation via inhibiting HMGB1-related pro-inflammatory signals in lipopolysaccharide-induced inflammation model in C57BL\/6J mice. Int Immunopharmacol. 2019;68:95\u2013105.","journal-title":"Int Immunopharmacol"},{"key":"5302_CR37","doi-asserted-by":"publisher","first-page":"114384","DOI":"10.1016\/j.bbr.2023.114384","volume":"445","author":"P Jiang","year":"2023","unstructured":"Jiang P, et al. Icariin alleviates autistic-like behavior, hippocampal inflammation and vGlut1 expression in adult BTBR mice. Behav Brain Res. 2023;445:114384.","journal-title":"Behav Brain Res"},{"key":"5302_CR38","doi-asserted-by":"publisher","first-page":"136918","DOI":"10.1016\/j.neulet.2022.136918","volume":"791","author":"B Pan","year":"2022","unstructured":"Pan B, et al. Effects of Icariin on alleviating schizophrenia-like symptoms by regulating the miR-144-3p\/ATP1B2\/mTOR signalling pathway. Neurosci Lett. 2022;791:136918.","journal-title":"Neurosci Lett"},{"issue":"1","key":"5302_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.pbb.2007.04.009","volume":"87","author":"Y Pan","year":"2007","unstructured":"Pan Y, et al. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacol Biochem Behav. 2007;87(1):130\u201340.","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"5302_CR40","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.psyneuen.2009.06.020","volume":"35","author":"Y Pan","year":"2010","unstructured":"Pan Y, et al. Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats. Psychoneuroendocrinology. 2010;35(2):272\u201383.","journal-title":"Psychoneuroendocrinology"},{"key":"5302_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fnins.2019.00291","volume":"13","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. Icariin attenuates M1 activation of microglia and A\u03b2 plaque accumulation in the hippocampus and prefrontal cortex by up-regulating PPAR\u03b3 in restraint\/isolation-stressed APP\/PS1 mice. Front Neurosci. 2019;13:291.","journal-title":"Front Neurosci"},{"issue":"1","key":"5302_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3892\/ijmm.2016.2591","volume":"38","author":"K Wei","year":"2016","unstructured":"Wei K, et al. Icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress. Int J Mol Med. 2016;38(1):337\u201344.","journal-title":"Int J Mol Med"},{"key":"5302_CR43","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbr.2013.09.034","volume":"256","author":"X Wu","year":"2013","unstructured":"Wu X, et al. Icaritin opposes the development of social aversion after defeat stress via increases of GR mRNA and BDNF mRNA in mice. Behav Brain Res. 2013;256:602\u20138.","journal-title":"Behav Brain Res"},{"issue":"1","key":"5302_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5246\/jcps.2021.01.003","volume":"30","author":"X Yu","year":"2021","unstructured":"Yu X, et al. The antidepressive effect of the complex consisting of radix Pseudostellariae, radix pueraria and herba epimedii: the involvement of NRSF\/NRSE-TPH2 signaling. J Chin Pharm Sci. 2021;30(1):27\u201341.","journal-title":"J Chin Pharm Sci"},{"issue":"3","key":"5302_CR45","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4103\/1673-5374.320993","volume":"17","author":"NX Zeng","year":"2022","unstructured":"Zeng NX, et al. Exploration of the mechanism by which Icariin modulates hippocampal neurogenesis in a rat model of depression. Neural Regen Res. 2022;17(3):632\u201342.","journal-title":"Neural Regen Res"},{"issue":"15","key":"5302_CR46","first-page":"1280","volume":"53","author":"C Zhang","year":"2018","unstructured":"Zhang C, et al. Effect of Icariin on behavior and monoamine neurotransmitters in rats with depression induced by chronic unpredicted mild stress. Chin Pharm J. 2018;53(15):1280\u20134.","journal-title":"Chin Pharm J"},{"key":"5302_CR47","doi-asserted-by":"publisher","first-page":"155507","DOI":"10.1016\/j.phymed.2024.155507","volume":"128","author":"DX Zhang","year":"2024","unstructured":"Zhang DX, et al. Icariin mitigates anxiety-like behaviors induced by hemorrhagic shock and resuscitation via inhibiting astrocytic activation. Phytomedicine. 2024;128:155507.","journal-title":"Phytomedicine"},{"issue":"7","key":"5302_CR48","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.braindev.2017.03.021","volume":"39","author":"X Zhang","year":"2017","unstructured":"Zhang X, et al. Antidepressant-like activity of Icariin mediated by group I mGluRs in prenatally stressed offspring. Brain Dev. 2017;39(7):593\u2013600.","journal-title":"Brain Dev"},{"key":"5302_CR49","doi-asserted-by":"crossref","unstructured":"Dong Y et al. Evidence for action of Icariin on depressive behavior in prenatal stress offspring rats and mechanism by integrating metabolomics and network Pharmacology. Phytomedicine. 2025;146:157132.","DOI":"10.1016\/j.phymed.2025.157132"},{"key":"5302_CR50","doi-asserted-by":"publisher","first-page":"120036","DOI":"10.1016\/j.jep.2025.120036","volume":"350","author":"H Zhao","year":"2025","unstructured":"Zhao H, et al. Icariin mitigates depressive-like behavior in rats by regulating mitochondrial function. J Ethnopharmacol. 2025;350:120036.","journal-title":"J Ethnopharmacol"},{"key":"5302_CR51","doi-asserted-by":"publisher","first-page":"111264","DOI":"10.1016\/j.brainresbull.2025.111264","volume":"222","author":"L Gu","year":"2025","unstructured":"Gu L, et al. Discovery and validation of CREB1 as a transcription target of icaritin: implications for the treatment of depressive-like behavior. Brain Res Bull. 2025;222:111264.","journal-title":"Brain Res Bull"},{"key":"5302_CR52","doi-asserted-by":"publisher","first-page":"119550","DOI":"10.1016\/j.ijpharm.2020.119550","volume":"586","author":"D Xu","year":"2020","unstructured":"Xu D, et al. Intranasal delivery of Icariin via a nanogel-thermoresponsive hydrogel compound system to improve its antidepressant-like activity. Int J Pharm. 2020;586:119550.","journal-title":"Int J Pharm"},{"issue":"1","key":"5302_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00210-023-02615-1","volume":"397","author":"X Di","year":"2024","unstructured":"Di X, et al. Exploring the mechanism of Icariin in the treatment of depression through BDNF-TrkB pathway based on network Pharmacology. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(1):463\u201378.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"5302_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.14715\/cmb\/2023.69.7.32","volume":"69","author":"X Wu","year":"2023","unstructured":"Wu X, et al. Icariin prevents depression-like behaviors in chronic unpredictable mild stress-induced rats through Bax\/cyt.c\/caspase-3 axis to alleviate neuronal apoptosis. Cell Mol Biol. 2023;69(7):196\u2013204.","journal-title":"Cell Mol Biol"},{"issue":"3","key":"5302_CR55","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.18632\/aging.203893","volume":"14","author":"LR Li","year":"2022","unstructured":"Li LR, et al. The neuroprotective effects of Icariin on ageing, various neurological, neuropsychiatric disorders, and brain injury induced by radiation exposure. Aging. 2022;14(3):1562\u201388.","journal-title":"Aging"},{"key":"5302_CR56","doi-asserted-by":"publisher","first-page":"971817","DOI":"10.1155\/2013\/971817","volume":"2013","author":"S Capoccia","year":"2013","unstructured":"Capoccia S, et al. Quality and timing of stressors differentially impact on brain plasticity and neuroendocrine-immune function in mice. Neural Plast. 2013;2013:971817.","journal-title":"Neural Plast"},{"key":"5302_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0248-8663(86)80065-0","volume":"Spec No","author":"Y Juillet","year":"1986","unstructured":"Juillet Y, Abadie E. [Comment d\u00e9terminer Le dosage optimal d\u2019un m\u00e9dicament]. Rev Med Interne. 1986;Spec No:21\u20137.","journal-title":"Rev Med Interne"},{"issue":"2","key":"5302_CR58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2203\/dose-response.08-019.Peper","volume":"7","author":"A Peper","year":"2009","unstructured":"Peper A. Aspects of the relationship between drug dose and drug effect. Dose Response. 2009;7(2):172\u201392.","journal-title":"Dose Response"},{"issue":"1\u20132","key":"5302_CR59","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jnr.23861","volume":"95","author":"N Kokras","year":"2017","unstructured":"Kokras N, Dalla C. Preclinical sex differences in depression and antidepressant response: implications for clinical research. J Neurosci Res. 2017;95(1\u20132):731\u20136.","journal-title":"J Neurosci Res"},{"issue":"9","key":"5302_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11920-017-0812-8","volume":"19","author":"PJ Raue","year":"2017","unstructured":"Raue PJ, et al. Advances in psychotherapy for depressed older adults. Curr Psychiatry Rep. 2017;19(9):57.","journal-title":"Curr Psychiatry Rep"},{"key":"5302_CR61","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.2147\/IJN.S520768","volume":"20","author":"H Wu","year":"2025","unstructured":"Wu H, et al. Brain delivery strategies for biomacromolecular drugs: intranasal administration. Int J Nanomed. 2025;20:6463\u201387.","journal-title":"Int J Nanomed"},{"issue":"3","key":"5302_CR62","doi-asserted-by":"publisher","first-page":"352","DOI":"10.30802\/AALAS-JAALAS-24-131","volume":"64","author":"F Mohseni","year":"2025","unstructured":"Mohseni F, Rafaiee R, Opinion. Ethical challenges in depression research: the tail suspension Test, the forced swim Test, and alternative behavioral models. J Am Assoc Lab Anim Sci. 2025;64(3):352\u20135.","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"5","key":"5302_CR63","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s13205-025-04275-9","volume":"15","author":"G Khanjari","year":"2025","unstructured":"Khanjari G, et al. Neuroprotective effects of the Elderberry diet on the methamphetamine-induced toxicity in rats: a behavioral, electrophysiological, and histopathological study. 3 Biotech. 2025;15(5):122.","journal-title":"3 Biotech"},{"key":"5302_CR64","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ibneur.2025.04.011","volume":"18","author":"R Tamannaeifar","year":"2025","unstructured":"Tamannaeifar R, et al. Vitamin D and brain volumetric changes: an updated systematic review and meta-analysis. IBRO Neurosci Rep. 2025;18:844\u201352.","journal-title":"IBRO Neurosci Rep"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05302-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05302-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05302-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:02:33Z","timestamp":1774890153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-026-05302-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5302"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05302-9","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No research involving human participants, human material, or human data was conducted; therefore, ethics approval and informed consent were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form (including individual details, images, or videos), and therefore consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}